US STOCK
INSM Stock Analysis
US stocks · market data · technical indicators
Insmed Incorporated
INSMUS stocksQuote delayed 15 min
10/26 上午10:31 updated
$93.39
-1.67-1.76%
Open
$94.12
High
$94.64
Low
$92.63
Volume
341.43萬
INSM price history
-20.63%Open
117.67
Latest
93.39
High
117.67
Low
93.39
Average
102.05
Advertisement
Financial snapshot
INSM - Insmed Incorporated
EPS
-4.10USD
Forward EPS
0.75USD
P/E
--
Forward P/E
124.21x
P/B
26.91x
ROE
-87.22%
ROA
-22.17%
Operating margin
-23.81%
Profit margin
-76.94%
Revenue growth
296.10%
Earnings growth
--
Dividend yield
0.00%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $425.49M | $305.96M | $263.84M | $142.34M | $107.42M |
| Gross profit | $358.27M | $258.54M | $219.62M | $112.98M | $79.34M |
| Operating income | -$101.31M | -$200.28M | -$249.71M | -$261.35M | -$253.88M |
| Net income | -$13.24M | -$163.56M | -$328.49M | -$370.02M | -$321.69M |
| Basic EPS | -0.06 | -0.76 | -1.54 | -1.75 | -1.70 |
| Diluted EPS | -0.06 | -0.76 | -1.54 | -1.75 | -1.70 |
Estimates vs actuals
Next earnings
2026-10-29
EPS estimate
-0.38
Revenue estimate
$499.48M
Last surprise
+91.21%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-10-29 | -0.38 | Not reported | — |
| 2026-08-06 | -0.68 | -0.06 | +91.21% |
| 2026-05-07 | -1.00 | -0.76 | +23.93% |
| 2026-02-19 | -1.17 | -1.54 | -31.92% |
| 2025-10-30 | -1.37 | -1.75 | -27.80% |
| 2025-08-07 | -1.31 | -1.70 | -29.60% |
| 2025-05-08 | -1.36 | -1.42 | -4.22% |
| 2025-02-20 | -1.16 | -1.32 | -13.32% |
| 2024-10-31 | -1.25 | -1.27 | -1.91% |
| 2024-08-08 | -1.23 | -1.94 | -58.20% |
| 2024-05-09 | -1.20 | -1.06 | +11.47% |
| 2024-02-22 | -1.13 | -1.28 | -13.27% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $3.7B | 0.05% |
| BlackRock Inc. | 2024-06-30 | $955.7M | 0.02% |
| STATE STREET CORP | 2026-06-30 | $645.3M | 0.02% |
| CITADEL ADVISORS LLC | 2026-06-30 | $272.6M | 0.03% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $132.4M | 0.10% |
| Bridgewater Associates, LP | 2026-06-30 | $48.6M | 0.20% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$196.14
Target range
$165.00 – $243.00
Implied upside
110.02%
Strong buy
5
Buy
18
Hold
1
Sell
0
Strong sell
0
Advertisement